Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000938988 | SCV001084821 | benign | Congenital muscular hypertrophy-cerebral syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001288777 | SCV001476126 | benign | not specified | 2020-02-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002454145 | SCV002616906 | likely benign | Inborn genetic diseases | 2016-09-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002502874 | SCV002796149 | likely benign | Congenital muscular hypertrophy-cerebral syndrome; Developmental and epileptic encephalopathy, 85, with or without midline brain defects | 2021-11-29 | criteria provided, single submitter | clinical testing |